The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group


  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia Group
  4. Cochrane Back Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
    1. About this group
    2. Reviews
      1. Addition of drug/s to a chemotherapy regimen for metastatic breast cancerReview
      2. Antibiotics / anti-inflammatories for reducing acute inflammatory episodes in lymphoedema of the limbsReviewWithdrawn
      3. Antitumour antibiotic containing regimens for metastatic breast cancerReview
      4. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal womenReview
      5. Benzo-pyrones for reducing and controlling lymphoedema of the limbsReview
      6. Bisphosphonates and other bone agents for breast cancerReview
      7. Cancer genetic risk assessment for individuals at risk of familial breast cancerReview
      8. Chemotherapy alone versus endocrine therapy alone for metastatic breast cancerReview
      9. Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patientsReview
      10. Combination versus sequential single agent chemotherapy for metastatic breast cancerReview
      11. Exercise for women receiving adjuvant therapy for breast cancerReview
      12. Exercise interventions for upper-limb dysfunction due to breast cancer treatmentReview
      13. Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and axillary surgeryReview
      14. Follow-up strategies for women treated for early breast cancerReview
      15. Fraction size in radiation treatment for breast conservation in early breast cancerReview
      16. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancerReview
      17. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancerReview
      18. Immediate versus delayed reconstruction following surgery for breast cancerReview
      19. Interventions for relieving the pain and discomfort of screening mammographyReview
      20. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal womenReview
      21. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average riskReview
      22. Methods of communicating a primary diagnosis of breast cancer to patientsReview
      23. Multi-agent chemotherapy for early breast cancerReviewWithdrawn
      24. Multidisciplinary rehabilitation for follow-up of women treated for breast cancerReview
      25. Non-hormonal interventions for hot flushes in women with a history of breast cancerReview
      26. Ovarian ablation for early breast cancerReviewWithdrawn
      27. Partial breast irradiation for early breast cancerReview
      28. Physical therapies for reducing and controlling lymphoedema of the limbsReview
      29. Platinum containing regimens for metastatic breast cancerReview
      30. Post-operative radiotherapy for ductal carcinoma in situ of the breastReview
      31. Postoperative tamoxifen for ductal carcinoma in situReview
      32. Preoperative chemotherapy for women with operable breast cancerReview
      33. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patientsReview
      34. Prophylactic mastectomy for the prevention of breast cancerReview
      35. Psychological interventions for women with metastatic breast cancerReview
      36. Radiotherapy for early breast cancerReviewWithdrawn
      37. Regular self-examination or clinical examination for early detection of breast cancerReview
      38. Screening for breast cancer with mammographyReview
      39. Sequencing of chemotherapy and radiotherapy for early breast cancerReview
      40. Single agent versus combination chemotherapy for metastatic breast cancerReview
      41. Specialist breast care nurses for supportive care of women with breast cancerReview
      42. Strategies for increasing the participation of women in community breast cancer screeningReview
      43. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)Review
      44. Systemic therapy for treating locoregional recurrence in women with breast cancerReview
      45. Tamoxifen for early breast cancerReviewWithdrawn
      46. Taxane containing regimens for metastatic breast cancerReview
      47. Taxanes for adjuvant treatment of early breast cancerReview
      48. Timing of breast surgery in premenopausal breast cancer patientsReview
      49. Toremifene versus tamoxifen for advanced breast cancerReview
      50. Trastuzumab containing regimens for early breast cancerReview
      51. Trastuzumab-containing regimens for metastatic breast cancerReview
      52. Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancerReview
      53. Wound drainage after axillary dissection for carcinoma of the breastReview
    3. Protocols
      1. Acupuncture for treatment-related side effects in women with breast cancerProtocol
      2. Aromatase Inhibitors for the adjuvant treatment of breast cancer in postmenopausal womenProtocol
      3. Autologous fat grafting for breast reconstructionProtocol
      4. Axillary staging for operable primary breast cancer.Protocol
      5. Bisphosphonates for prevention of bone loss in women with early breast cancerProtocol
      6. Capecitabine for ER-positive versus ER-negative breast cancerProtocolNew
      7. Complete decongestive therapy for lymphedema following breast cancer treatmentProtocol
      8. Conventional interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapyProtocol
      9. Different types of implants for reconstructive breast surgeryProtocol
      10. Duration of chemotherapy for metastatic breast cancerProtocol
      11. Fulvestrant for hormone-sensitive metastatic breast cancerProtocol
      12. Home-based multidimensional survivorship programmes for breast cancer survivorsProtocol
      13. Intensity-modulated versus conventional radiotherapy for breast cancerProtocol
      14. Lapatinib for metastatic breast cancer overexpressing HER2Protocol
      15. Localization techniques for guided surgical excision of non-palpable breast lesionsProtocol
      16. Nipple- and areola-sparing mastectomy for the treatment of breast cancerProtocol
      17. Post-mastectomy radiotherapy for breast cancer patients with 1 to 3 positive lymph nodesProtocol
      18. Psychological interventions for women with non-metastatic breast cancerProtocol
      19. Skin-sparing mastectomy for the treatment of breast cancerProtocol
      20. Yoga for women diagnosed with breast cancerProtocol
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Consumers and Communication Group
  10. Cochrane Cystic Fibrosis and Genetic Disorders Group
  11. Cochrane Dementia and Cognitive Improvement Group
  12. Cochrane Depression, Anxiety and Neurosis Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Ear, Nose and Throat Disorders Group
  16. Cochrane Effective Practice and Organisation of Care Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological Cancer Group
  21. Cochrane Haematological Malignancies Group
  22. Cochrane Heart Group
  23. Cochrane Hepato-Biliary Group
  24. Cochrane HIV/AIDS Group
  25. Cochrane Hypertension Group
  26. Cochrane Incontinence Group
  27. Cochrane Infectious Diseases Group
  28. Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group
  29. Cochrane Injuries Group
  30. Cochrane Lung Cancer Group
  31. Cochrane Menstrual Disorders and Subfertility Group
  32. Cochrane Metabolic and Endocrine Disorders Group
  33. Cochrane Methodology Review Group
  34. Cochrane Movement Disorders Group
  35. Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group
  36. Cochrane Musculoskeletal Group
  37. Cochrane Neonatal Group
  38. Cochrane Neuromuscular Disease Group
  39. Cochrane Occupational Safety and Health Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Peripheral Vascular Diseases Group
  43. Cochrane Pregnancy and Childbirth Group
  44. Cochrane Prostatic Diseases and Urologic Cancers Group
  45. Cochrane Public Health Group
  46. Cochrane Renal Group
  47. Cochrane Schizophrenia Group
  48. Cochrane Sexually Transmitted Infections Group
  49. Cochrane Skin Group
  50. Cochrane Stroke Group
  51. Cochrane Tobacco Addiction Group
  52. Cochrane Upper Gastrointestinal and Pancreatic Diseases Group
  53. Cochrane Wounds Group

SEARCH